Revised MRPs post GST rate reduction, effective 22nd September – Making healthcare more affordable. Learn More
Press Release

Gas-O-Fast Rolls Out “Mon Matano Ganer Sanda (Soulful Musical Evening),” a Nine-City Musical Celebration Across West Bengal

Share

Mankind Pharma, India’s fourth-largest pharmaceutical company, has rolled out “Mon Matano Ganer Sanda (Soulful Musical Evening),” a nine-city musical tour presented by its leading homegrown antacid brand, Gas-O-Fast. The initiative celebrates Bengal’s cultural spirit through music and community gatherings, co-supported by Nimulid Strong and Health OK. The tour began on 5 December 2025 and will continue until 3 January 2026, featuring performances by renowned Bengali artists Bishwanath Basu, Iman Chakraborty and Jojo. All events offer free entry on a first-come, first-served basis.

The tour is travelling through key locations including Burdwan, Bankura, Medinipur, Nadia, Kakdip, Basirhat, Malda, Jalpaiguri and Coochbehar, bringing communities together in a format inspired by the traditional macha shows popular across rural Bengal. Each evening is curated as a cultural experience with live performances, food stalls, local touchpoints and family-friendly engagement zones. With the year-end festive period underway, the tour offers families a space to come together, unwind and celebrate their shared cultural traditions.

Gas-O-Fast holds a strong presence in West Bengal, with a state market share of approximately 24 percent and around 12 percent nationally (Source: IQVIA). The brand’s jeera-based formulation, rooted in Indian traditions, continues to resonate with consumers across the state and the country. The initiative aims to strengthen the brand’s cultural connect in a market where Gas-O-Fast already enjoys deep-rooted consumer trust. Along with Gas-O-Fast, the tour is supported by two of Mankind Pharma’s consumer brands, Nimulid Strong and Health OK. Their participation reflects the company’s broader engagement with households in West Bengal, where both brands are familiar to consumers and form part of its growing over-the-counter portfolio. 

On-ground and print-led promotions, including banners, hoardings, Toto announcements and local outreach, have been activated to build awareness across the tour locations. At each venue, dedicated brand stalls offer simple touchpoints for consumer interaction and sampling.

Joy Chatterjee, Vice President, Sales and Marketing Head, Consumer Business Unit, Mankind Pharma, commented: “West Bengal has always been a key market for us, and the relationship our brands enjoy with consumers here is something we deeply value. Music brings people together in a way few other formats can, and the macha-style setup has a special place in the cultural fabric of the state. Mon Matano Ganer Sanda allows us to connect with communities through an experience that feels familiar, inclusive and genuinely enjoyed across districts. Gas-O-Fast already has a strong presence in Bengal, and this initiative also gives us an opportunity to build a closer connection for Nimulid Strong and Health OK so that, over time, they too become trusted household names in the region.”

As the tour continues across West Bengal, Gas-O-Fast looks forward to engaging with communities in a setting that reflects the region’s cultural warmth. Through this initiative, the company aims to deepen its relationship with consumers and continue building a presence that feels rooted, relevant and locally connected.

About Mankind Pharma

Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical company in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, antidiabetic, neuro/CNS, gynaecology, VMN and respiratory, among others with a strategy to increase chronic presence going ahead. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. Following the acquisition of Bharat Serums and Vaccines Limited, Mankind Pharma has further strengthened its leadership in the domestic women’s health segment. Mankind’s distribution network includes a robust field force of 17,700+ professionals, and a reach extending to over five lakh doctors across urban and rural markets. The company has 30 manufacturing facilities in India manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seal, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products. Mankind has a consistent track record of product innovation through 6 dedicated R&D facilities backed by more than 730 scientists.

 

For more information, visit www.mankindpharma.com or contact:

Natasha Raj – 9205057627 – natasha.raj@mankindpharma.com

Apoorva Sharma – 9999739452 – apoorva.sharma@adfactorspr.com